-
BMO Capital Downgrades Clinical Data (CLDA) to Market Perform
-
Clinical Data (CLDA) Closes 2.24M Common Offering at $14.30/Share; Over-Allotment Option Fully Exercised
-
Clinical Data (CLDA) Announces Common Offering
-
BMO Capital Initiates Coverage on Clinical Data (CLDA) with an Outperform
